Menghisteab Bairu
CIK: 0001891933
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Director
Discretionary Trading P&L
Holdings
About Bairu Menghisteab
Bairu Menghisteab (SEC CIK 0001891933) files insider reports with the SEC as Director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 2 ownership filings by Bairu Menghisteab, all Form 4s, filed between Jan 3, 2025 and May 20, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bairu Menghisteab's filings is in NEW YORK, NY.
Recent filings by Bairu Menghisteab
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Pitts Peter Joe, Executive Chairman
- Lebovits Chaim, President & CEO
- Yablonka Uri, EVP & Chief Business Officer
- Patlis Alla
- ARBEL IRIT, Director